172 related articles for article (PubMed ID: 31686441)
1. Experience Profiling of Fluorescence-Guided Surgery II: Non-Glioma Pathologies.
Ji SY; Kim JW; Park CK
Brain Tumor Res Treat; 2019 Oct; 7(2):105-111. PubMed ID: 31686441
[TBL] [Abstract][Full Text] [Related]
2. Experience Profiling of Fluorescence-Guided Surgery I: Gliomas.
Ji SY; Kim JW; Park CK
Brain Tumor Res Treat; 2019 Oct; 7(2):98-104. PubMed ID: 31686440
[TBL] [Abstract][Full Text] [Related]
3. Impact of 5-aminolevulinic acid fluorescence-guided surgery on the extent of resection of meningiomas--with special regard to high-grade tumors.
Cornelius JF; Slotty PJ; Kamp MA; Schneiderhan TM; Steiger HJ; El-Khatib M
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):481-90. PubMed ID: 25117928
[TBL] [Abstract][Full Text] [Related]
4. What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
Hadjipanayis CG; Widhalm G; Stummer W
Neurosurgery; 2015 Nov; 77(5):663-73. PubMed ID: 26308630
[TBL] [Abstract][Full Text] [Related]
5. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma.
Tsugu A; Ishizaka H; Mizokami Y; Osada T; Baba T; Yoshiyama M; Nishiyama J; Matsumae M
World Neurosurg; 2011; 76(1-2):120-7. PubMed ID: 21839963
[TBL] [Abstract][Full Text] [Related]
6. Optimization of high-grade glioma resection using 5-ALA fluorescence-guided surgery: A literature review and practical recommendations from the neuro-oncology club of the French society of neurosurgery.
Picart T; Berhouma M; Dumot C; Pallud J; Metellus P; Armoiry X; Guyotat J
Neurochirurgie; 2019 Aug; 65(4):164-177. PubMed ID: 31125558
[TBL] [Abstract][Full Text] [Related]
7. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
[TBL] [Abstract][Full Text] [Related]
8. Use of fluorescence to guide resection or biopsy of primary brain tumors and brain metastases.
Marbacher S; Klinger E; Schwyzer L; Fischer I; Nevzati E; Diepers M; Roelcke U; Fathi AR; Coluccia D; Fandino J
Neurosurg Focus; 2014 Feb; 36(2):E10. PubMed ID: 24484248
[TBL] [Abstract][Full Text] [Related]
9. Analysis of 5-aminolevulinic acid-induced fluorescence in 55 different spinal tumors.
Millesi M; Kiesel B; Woehrer A; Hainfellner JA; Novak K; Martínez-Moreno M; Wolfsberger S; Knosp E; Widhalm G
Neurosurg Focus; 2014 Feb; 36(2):E11. PubMed ID: 24484249
[TBL] [Abstract][Full Text] [Related]
10. 5-ALA fluorescence on tumors different from malignant gliomas. Review of the literature and our experience.
Boschi A; Della Puppa A
J Neurosurg Sci; 2019 Dec; 63(6):661-669. PubMed ID: 31355622
[TBL] [Abstract][Full Text] [Related]
11. Quantification of PpIX-fluorescence of cerebral metastases: a pilot study.
Knipps J; Fischer I; Neumann LM; Rapp M; Dibué-Adjei M; Freiin von Saß C; Placke JM; Mijderwijk HJ; Steiger HJ; Sabel M; Cornelius JF; Kamp MA
Clin Exp Metastasis; 2019 Oct; 36(5):467-475. PubMed ID: 31376098
[TBL] [Abstract][Full Text] [Related]
12. Intra-operative visualization of brain tumors with 5-aminolevulinic acid-induced fluorescence.
Widhalm G
Clin Neuropathol; 2014; 33(4):260-78. PubMed ID: 24986206
[TBL] [Abstract][Full Text] [Related]
13. Established and emerging uses of 5-ALA in the brain: an overview.
Díez Valle R; Hadjipanayis CG; Stummer W
J Neurooncol; 2019 Feb; 141(3):487-494. PubMed ID: 30607705
[TBL] [Abstract][Full Text] [Related]
14. Maximizing safe resections: the roles of 5-aminolevulinic acid and intraoperative MR imaging in glioma surgery-review of the literature.
Suero Molina E; Schipmann S; Stummer W
Neurosurg Rev; 2019 Jun; 42(2):197-208. PubMed ID: 28921173
[TBL] [Abstract][Full Text] [Related]
15. 5-Aminolevulinic acid fluorescence guided surgery for recurrent high-grade gliomas.
Chohan MO; Berger MS
J Neurooncol; 2019 Feb; 141(3):517-522. PubMed ID: 30097823
[TBL] [Abstract][Full Text] [Related]
16. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
17. The current status of 5-ALA fluorescence-guided resection of intracranial meningiomas-a critical review.
Motekallemi A; Jeltema HR; Metzemaekers JD; van Dam GM; Crane LM; Groen RJ
Neurosurg Rev; 2015 Oct; 38(4):619-28. PubMed ID: 25736455
[TBL] [Abstract][Full Text] [Related]
18. Spectroscopic measurement of 5-ALA-induced intracellular protoporphyrin IX in pediatric brain tumors.
Schwake M; Kaneko S; Suero Molina E; Müther M; Schipmann S; Köchling M; Brentrup A; Stummer W
Acta Neurochir (Wien); 2019 Oct; 161(10):2099-2105. PubMed ID: 31435824
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence Diagnosis in Neurooncology: Retrospective Analysis of 653 Cases.
Goryaynov SA; Okhlopkov VA; Golbin DA; Chernyshov KA; Svistov DV; Martynov BV; Kim AV; Byvaltsev VA; Pavlova GV; Batalov A; Konovalov NA; Zelenkov PV; Loschenov VB; Potapov AA
Front Oncol; 2019; 9():830. PubMed ID: 31552168
[No Abstract] [Full Text] [Related]
20. 5-Aminolevulinic acid fluorescence-guided surgery for spinal cord melanoma metastasis: a technical note.
Ruschel LG; Ramina R; da Silva EB; Cavalcanti MS; Duarte JFS
Acta Neurochir (Wien); 2018 Oct; 160(10):1905-1908. PubMed ID: 30091052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
